Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.390
-0.090 (-2.01%)
At close: May 19, 2026, 4:00 PM EDT
4.350
-0.040 (-0.91%)
After-hours: May 19, 2026, 7:58 PM EDT
Cingulate Employees
Cingulate had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
n/a
Profits / Employee
-$1,993,523
Market Cap
53.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 1 | 7.69% |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | -1 | -6.25% |
| Dec 31, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2021 | 13 | 1 | 8.33% |
| Jun 30, 2021 | 13 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| aTyr Pharma | 60 |
| BeyondSpring | 44 |
| Filana Therapeutics | 20 |
| iBio, Inc. | 20 |
| Instil Bio | 14 |
| Actuate Therapeutics | 12 |
| Dogwood Therapeutics | 8 |
| KALA BIO | 6 |
CING News
- 13 hours ago - Cingulate price target lowered to $10 from $14 at Roth Capital - TheFly
- 1 day ago - Cingulate Proxy statement: Proxy filing - Filings
- 5 days ago - Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301 - GlobeNewsWire
- 5 days ago - Cingulate Earnings release: Q1 2026 - Filings
- 5 days ago - Cingulate Quarterly report: Q1 2026 - Filings
- 27 days ago - Six new option listings on April 22nd - TheFly
- 5 weeks ago - Cingulate files to sell 4.21M shares of common stock for holders - TheFly
- 5 weeks ago - Cingulate Registration statement: Registration filing - Filings